$2.4M NIH Grant Supports Boston Team Creating Cell Model for IPF

A four-year, $2.4 million federal grant given investigators at Boston University School of Medicine (BUSM) will support work to create a 3D cell model system helping to explain the processes that initiate and drive the progression of idiopathic pulmonary fibrosis (IPF). According to a press release, the project will be…

New Knowledge About Ofev and Esbriet May Lead to Better Lung Fibrosis Therapies

By discovering how the antifibrotic treatments Ofev (nintedanib) and Esbriet (pirfenidone) work, researchers hope to develop even better drugs to treat pulmonary fibrosis. The new insights into these drugs work was gained by making use of a new cell model of lab-grown cells derived from patients. The study,…